Related Experiment Videos
Novel antipsychotic drugs share high affinity for sigma receptors
B L Largent1, H Wikström, A M Snowman
1Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
European Journal of Pharmacology
|October 18, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Robustness of a continuous direct compression line against disturbances in feeding.
International journal of pharmaceutics·2019
Smoking increases the incidence of complicated diverticular disease of the sigmoid colon.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2010
Enlarged SI and SII somatosensory evoked responses in the CLN5 form of neuronal ceroid lipofuscinosis.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2002
Identification and characterization of a novel inositol hexakisphosphate kinase.
The Journal of biological chemistry·2001
Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonists.
Bioorganic & medicinal chemistry·2001
Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues.
Journal of medicinal chemistry·2001
Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.
European journal of pharmacology·2026
Thymosin α-1 in Cancer Therapy: Immunomodulatory Mechanisms, Clinical Applications, and Translational Perspectives.
European journal of pharmacology·2026
Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing.
European journal of pharmacology·2026
MOTS-c in sepsis-induced cardiomyopathy: Mechanisms and translational potential.
European journal of pharmacology·2026
Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Drug design, development and therapy·2026
Medication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.
Therapeutics and clinical risk management·2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Frontiers in neuroscience·2026
Multidimensional characterization of heterogeneity in pesticide co-exposure patterns.
Frontiers in chemistry·2026
Frustration brake failure hypothesis of substance use disorders.
Frontiers in psychiatry·2026